Evaluation of Desensitization Therapy and Re-treatment of Eye Movement Information [EMDR] in Patients With Post-traumatic Stress Disorder [PTSD]
ICE-EMDR
1 other identifier
interventional
48
1 country
1
Brief Summary
This research aims to confirm that the therapeutic effect of EMDR is associated with changes in the interaction between cognitive function and emotional stimuli in PTSD patients compared to a controlled therapy in a randomized, single-blind study.On the other hand, this study aims to observe neuronal and cognitive correlates related to EMDR therapy compared to a control therapy. This investigation would improve the understanding of the mechanisms of action of the EMDR, still unknown to date.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 2, 2018
CompletedFirst Submitted
Initial submission to the registry
April 30, 2020
CompletedFirst Posted
Study publicly available on registry
June 16, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedFebruary 10, 2023
February 1, 2023
7.5 years
April 30, 2020
February 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Post Traumatic Stress Scale-5 (PCL-5)
The PCL-5 is a self-assessment consisting of 20 items that measures the 20 PTSD symptoms of the DSM-5. The wording of the PCL-5 items reflects both changes in existing symptoms and the addition of new symptoms in the DSM-5. The objectives of PCL-5 are numerous, such as monitoring changes in symptoms during and after treatment, screening individuals with PTSD, making an interim diagnosis of PTSD.
Before the therapy begins, at day 0
Post Traumatic Stress Scale-5
The PCL-5 is a self-assessment consisting of 20 items that measures the 20 PTSD symptoms of the DSM-5. The wording of the PCL-5 items reflects both changes in existing symptoms and the addition of new symptoms in the DSM-5. The objectives of PCL-5 are numerous, such as monitoring changes in symptoms during and after treatment, screening individuals with PTSD, making an interim diagnosis of PTSD.
Within 3 weeks before the end of the therapy
State Trait Anxiety Inventory (STAI)
The State-Trait Anxiety Inventory (STAI) is a psychological inventory based on a 4-point Likert scale and consists of 40 questions on a self-report basis. The STAI measures two types of anxiety - state anxiety, or anxiety about an event, and trait anxiety, or anxiety level as a personal characteristic. Higher scores are positively correlated with higher levels of anxiety.
Before the therapy begins, at day 0
State Trait Anxiety Inventory (STAI)
The State-Trait Anxiety Inventory (STAI) is a psychological inventory based on a 4-point Likert scale and consists of 40 questions on a self-report basis. The STAI measures two types of anxiety - state anxiety, or anxiety about an event, and trait anxiety, or anxiety level as a personal characteristic. Higher scores are positively correlated with higher levels of anxiety.
Within 3 weeks before the end of the therapy
The Short Form (36) Health Survey (SF36)
TheSF36isashortquestionnairewith36itemswhichmeasureeightmulti-itemvariables:physicalfunctioning(10items),socialfunctioning(twoitems),rolelimitationsduetophysicalproblems(fouritems),rolelimitationsduetoemotionalproblems(threeitems),mentalhealth(fiveitems),energyandvitality(fouritems),pain(twoitems),andgeneralperceptionofhealth(fiveitems).Foreachvariableitemscoresarecoded,summed,andtransformedontoascalefrom0(worstpossiblehealthstatemeasuredbythequestionnaire)to100(bestpossiblehealthstate).
Before the therapy begins, at day 0
The Short Form (36) Health Survey (SF36)
TheSF36isashortquestionnairewith36itemswhichmeasureeightmulti-itemvariables:physicalfunctioning(10items),socialfunctioning(twoitems),rolelimitationsduetophysicalproblems(fouritems),rolelimitationsduetoemotionalproblems(threeitems),mentalhealth(fiveitems),energyandvitality(fouritems),pain(twoitems),andgeneralperceptionofhealth(fiveitems).Foreachvariableitemscoresarecoded,summed,andtransformedontoascalefrom0(worstpossiblehealthstatemeasuredbythequestionnaire)to100(bestpossiblehealthstate).
Within 3 weeks before the end of the therapy
Childhood Trauma Questionnaire (CTQ)
The Childhood Trauma Questionnaire (CTQ) is a questionnaire developed by Bernstein et al. (1994) that includes 70 items with a Likert scale in five response choices (from 1 = "never true" to 5 = "very often true").
Before the therapy begins, at day 0
Childhood Trauma Questionnaire (CTQ)
The Childhood Trauma Questionnaire (CTQ) is a questionnaire developed by Bernstein et al. (1994) that includes 70 items with a Likert scale in five response choices (from 1 = "never true" to 5 = "very often true").
Within 3 weeks before the end of the therapy
Clinician Administered PTSD Scale for DSM-5[CAPS-5])
he CAPS-5 is a 30-item structured interview that can be used to: Make current (past month) diagnosis of PTSD,Make lifetime diagnosis of PTSD, Assess PTSD symptoms over the past week
Before the therapy begins, at day 0
Clinician Administered PTSD Scale for DSM-5[CAPS-5])
he CAPS-5 is a 30-item structured interview that can be used to: Make current (past month) diagnosis of PTSD,Make lifetime diagnosis of PTSD, Assess PTSD symptoms over the past week
Within 3 weeks before the end of the therapy
Clinical Global Impression (CGI)
The Clinical Global Impression (CGI) rating scales are measures of symptom severity, treatment response and the efficacy of treatments in treatment studies of patients with mental disorders
Before the therapy begins, at day 0
Clinical Global Impression (CGI)
The Clinical Global Impression (CGI) rating scales are measures of symptom severity, treatment response and the efficacy of treatments in treatment studies of patients with mental disorders
Within 3 weeks before the end of the therapy
Study Arms (2)
Patient for Eye Movement desensitization Reprocessing therapy
ACTIVE COMPARATORPatient with post-traumatic Stress Disorder will receive Eye Movement Desensitization reprocessing therapy
patients for Trauma-Centred Cognitive and Behavioural Therapy
PLACEBO COMPARATORPatients with post-traumatic Stress Disorder will receive Trauma-Centred Cognitive and Behavioural Therapy
Interventions
The Eye Movement Desensitization Reprocessing therapy uses bi-alternating (right-left) sensory stimulation through eye movements. The patient follows the therapist's fingers from right to left in front of his eyes and also by auditory stimuli. The patient wears a helmet that alternately makes him hear a sound to the right, then to the left or touch the patient holds in his hands buzzers that alternately vibrate from right to left, or alternatively the therapist taps the patient's knees or the back of his hands.
A CBT is a short, scientifically validated therapy that focuses on the interactions between thoughts, emotions and behaviours. These therapies focus on the current problems of the person, while taking into account their historical causes. They help gradually overcome disabling symptoms and aim to strengthen adaptive behaviours. A CBT relies on different techniques that help the patient to identify the mechanisms at the origin of his difficulties, to experiment with new behaviors and thus to gradually come out of vicious circles that perpetuate and aggravate the psychic suffering.
Eligibility Criteria
You may qualify if:
- Patient diagnosed with PTSD according to DSM 5 criteria (APA 2013) related to a single traumatic event,
- Aged 18 to 65 years,
- Signed informed consent.
- Patient with social security affiliation or State Medical Aid (AME)
You may not qualify if:
- Neurological disorders
- No other major psychiatric disorders than PTSD (DSM 5)
- Severe and/or unstable somatic pathologies,
- Patient not affiliated with social security,
- Patient hospitalized under stress in psychiatric care at the decision of the state representative or in psychiatric care at the request of a third party,
- Patient under guardianship,
- Patient participating in parallel with other biomedical research,
- Change of antidepressant during the last three months,
- Patient not fluent in French
- women of childbearing age without effective contraception or a positive pregnancy test,
- patients carrying pacemakers or electrical or electronic devices, clips or metal prostheses,
- subjects with neurological disorders, cerebral abnormalities or suffering from claustrophobia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ch Ville Evrard
Neuilly-sur-Marne, 93330, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dominique Januel, MBBS
CHVille Evrard
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of the clinical research department (psychiatrist)
Study Record Dates
First Submitted
April 30, 2020
First Posted
June 16, 2020
Study Start
July 2, 2018
Primary Completion
January 1, 2026
Study Completion
February 1, 2026
Last Updated
February 10, 2023
Record last verified: 2023-02